Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Virol ; 77(16): 8661-8, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12885884

ABSTRACT

We have previously shown that the nonstructural (NS) proteins NS1 and NS2 of bovine respiratory syncytial virus (BRSV) mediate resistance to the alpha/beta interferon (IFN)-mediated antiviral response. Here, we show that they, in addition, are able to prevent the induction of beta IFN (IFN-beta) after virus infection or double-stranded RNA stimulation. In BRSV-infected MDBK cells upregulation of IFN-stimulated genes (ISGs) such as MxA did not occur, although IFN signaling via JAK/STAT was found intact. In contrast, infection with recombinant BRSVs lacking either or both NS genes resulted in efficient upregulation of ISGs. Biological IFN activity and IFN-beta were detected only in supernatants of cells infected with the NS deletion mutants but not with wild-type (wt) BRSV. Subsequent analyses of IFN-beta promoter activity showed that infection of cells with the double deletion mutant BRSV DeltaNS1/2, but not with BRSV wt, resulted in a significant increase in IFN-beta gene promoter activity. Induction of the IFN-beta promoter depends on the activation of three distinct transcription factors, NF-kappaB, ATF-2/c-Jun, and IFN regulatory factor 3 (IRF-3). Whereas NF-kappaB and ATF-2/c-Jun activities were readily detectable and comparable in both wt BRSV- and BRSV DeltaNS1/2-infected cells, phosphorylation and transcriptional activity of IRF-3, however, were observed only after BRSV DeltaNS1/2 infection. NS protein-mediated inhibition of IRF-3 activation and IFN induction should have considerable impact on the pathogenesis and immunogenicity of BRSV.


Subject(s)
DNA-Binding Proteins/antagonists & inhibitors , Respiratory Syncytial Virus, Bovine/physiology , Transcription Factors/antagonists & inhibitors , Viral Nonstructural Proteins/physiology , Virus Activation/physiology , Animals , Cell Line , DNA-Binding Proteins/physiology , Gene Deletion , Interferon Regulatory Factors , Interferon-beta/genetics , Promoter Regions, Genetic , Signal Transduction , Transcription Factors/physiology , Viral Nonstructural Proteins/genetics , Viral Proteins
2.
J Virol ; 76(9): 4287-93, 2002 May.
Article in English | MEDLINE | ID: mdl-11932394

ABSTRACT

Bovine respiratory syncytial virus (BRSV) escapes from cellular responses to alpha/beta interferon (IFN-alpha/beta) by a concerted action of the two viral nonstructural proteins, NS1 and NS2. Here we show that the NS proteins of human RSV (HRSV) are also able to counteract IFN responses and that they have the capacity to protect replication of an unrelated rhabdovirus. Even combinations of BRSV and HRSV NS proteins showed a protective activity, suggesting common mechanisms and cellular targets of HRSV and BRSV NS proteins. Although able to cooperate, NS proteins from BRSV and HRSV showed differential protection capacity in cells from different hosts. A chimeric BRSV with HRSV NS genes (BRSV h1/2) was severely attenuated in bovine IFN competent MDBK and Klu cells, whereas it replicated like BRSV in IFN-incompetent Vero cells or in IFN-competent human HEp-2 cells. After challenge with exogenous IFN-alpha, BRSV h1/2 was better protected than wild-type BRSV in human HEp-2 cells. In contrast, in cells of bovine origin, BRSV h1/2 was much less resistant to exogenous IFN than wild-type BRSV. These data demonstrate that RSV NS1 and NS2 proteins are major determinants of host range. The differential IFN escape capacity of RSV NS proteins in cells from different hosts provides a basis for rational development of attenuated live RSV vaccines.


Subject(s)
Interferons/pharmacology , Respiratory Syncytial Virus, Bovine/growth & development , Respiratory Syncytial Virus, Human/growth & development , Viral Nonstructural Proteins , Animals , Cattle , Cell Line , Humans , Interferons/immunology , Recombination, Genetic , Respiratory Syncytial Virus Vaccines , Respiratory Syncytial Virus, Bovine/drug effects , Respiratory Syncytial Virus, Bovine/genetics , Respiratory Syncytial Virus, Bovine/metabolism , Respiratory Syncytial Virus, Human/drug effects , Respiratory Syncytial Virus, Human/genetics , Respiratory Syncytial Virus, Human/metabolism , Vaccines, Attenuated , Viral Nonstructural Proteins/genetics , Viral Nonstructural Proteins/immunology , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL
...